skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

22 Total results for product and free and sample content found


Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine logo

Several countries already are calling about orders, as the company prepares to begin a Phase III trial of its mRNA coronavirus vaccine candidate.

Topic Coronavirus Vaccines


Seizing The Day: How Coronavirus Breaks Then Makes Vaccine Makers In China


Amid fears of a second wave of coronavirus infections and the increasing dominance of state-owned enterprises, private vaccine makers in China are struggling to make the best of the outbreak, BravoVax CEO Ke Wu tells Scrip in an exclusive interview.

Topic Coronavirus Vaccines Clinical Trials


CanSino Claims Lead In COVID-19 Vaccine Race And Takes Swipe At Moderna's Ethics

Vaccines veteran calls Moderna ‘shabby’ for lack of transparency and shares sell-off, and flags CanSino’s own forthcoming Phase II results.

Topic Coronavirus Clinical Trials Vaccines


Coronavirus Update: CureVac Joins mRNA Vaccines Competitors, Beijing In Lockdown Again

Coronavirus Update CureVac Joins mRNA

CureVac starts mRNA vaccine trial, Interprotein uses AI in drug discovery and South Korea's Chong Kun and Hanmi make clinical progress.

Topic Coronavirus Vaccines


Coronavirus Update: India Approves Remdesivir, Ex-Biogen Employee Charged


A former employee of Biogen is officially charged in China for allegedly jeopardizing public health, Wuhan tests 10 million residents, India approves remdesivir.

Topic Coronavirus Vaccines

Generics Bulletin

Celltrion Will Trial COVID-19 Antiviral From July


Celltrion has made progress in finding an effective treatment for COVID-19 by identifying 14 antibodies able to neutralize coronavirus. The company aims to eventually roll out mass production of a therapeutic antibody treatment after starting human trials this July.

Topic Coronavirus Vaccines


Inovio Confirms Frontrunner Status In COVID-19

Its ‘virus chasing’ habits has given Inovio a bad reputation. But with backing from CEPI and Bill Gates, it has a chance to prove the doubters wrong.

Topic Coronavirus Vaccines

Pink Sheet

US Researchers Working Toward Universal Coronavirus Vaccine

Coronavirus Vaccine

The SARS-CoV-2 outbreak has the federal government working not only on a vaccine candidate specifically targeted at the novel coronavirus but also thinking more broadly about ways to head off future potential pandemics with emerging pathogens.

Pink Sheet

Coronavirus Supply Chain Threats Demand Coordinated Industry Response

Emergency Agency Meeting

Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: